Standard Contracts
LENZ THERAPEUTICS, INC. Confirmatory Employment LetterConfirmatory Employment Letter • December 6th, 2023 • Graphite Bio, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledDecember 6th, 2023 Company IndustryThis letter agreement (the “Agreement”) is entered into between LENZ Therapeutics, Inc. (the “Company” or “we”) and you. This Agreement is effective as of the later of the Closing (as defined below) or the date signed below (the “Effective Date”). The purpose of this Agreement is to confirm the terms and conditions of your employment with the Company as of the Effective Date.
PRESBYOPIA THERAPIES, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCKWarrant Agreement • December 6th, 2023 • Graphite Bio, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledDecember 6th, 2023 Company Industry JurisdictionTHIS CERTIFIES THAT, for value received, the Holder set forth above is entitled to subscribe for and purchase from Presbyopia Therapies, Inc., a Delaware corporation (the “Company”) shares of Class A common stock, par value $0.0001 per share, of the Company (the “Class A Common Stock”) as set forth below.
PRESBYOPIA THERAPIES, INC. WARRANT TO PURCHASE SHARES OF SERIES A PREFERRED STOCKWarrant Agreement • December 6th, 2023 • Graphite Bio, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledDecember 6th, 2023 Company Industry JurisdictionTHIS WARRANT CERTIFIES THAT, for good and valuable consideration, ____________________ or its assigns (the “Holder”) is entitled to purchase the number of fully paid and non-assessable shares of Series A Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), of Presbyopia Therapies, Inc., a Delaware corporation (the “Company”) as set forth below and subject to the provisions and upon the terms and conditions set forth in this Warrant. This Warrant is one of a series of warrants being issued by the Company in connection with the transactions contemplated by that certain Series A Stock Purchase Agreement dated as of October 30, 2020 by and between the Company, the Holder and the other Purchasers party thereto (the “Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings set forth in the Purchase Agreement.